Xenograft transplantation

Anesthesiology Clinics of North America

Volumn 22, Issue 4, 2004, Pages 871-885

  Khalpey, Zain ^a,b   Koch, Cody A ^a,b   Platt, Jeffrey L ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; DRUG SAFETY; GENETIC ENGINEERING; HUMAN; HUMORAL IMMUNITY; INFECTION; LIVER TOXICITY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE METABOLISM; ORGANOGENESIS; PARKINSON DISEASE; REVIEW; THROMBOSIS; VACCINATION; VASCULAR DISEASE; VASCULARIZATION; XENOGRAFT;

ANESTHESIA; ANIMALS; FORECASTING; GRAFT SURVIVAL; HUMANS; TRANSPLANTATION, HETEROLOGOUS;

EID: 8444226337     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.05.005     Document Type: Review

References (71)

1. Buckley R.H. Transplantation immunology: organ and bone marrow. J Allergy Clin Immunol. 111(Suppl 2):2003;S733-S744
2. Cecka J.M., Terasaki P.I. Clinical transplants 2001. 2002;UCLA Immunogenetics Center, Los Angeles
3. Platt J.L., Prather RS for the Council for Agricultural Science and Technology. Animal organ donors-human health applications. Issue paper No.26. Ames, Iowa: CAST
4. Harper A.M., Rosendale J.D. The UNOS OPTN waiting list and donor registry: 1988-1996. Terasaki P.I., Cecka J.M. Clinical transplants 1996. 1996;69 UCLA Tissue Typing Laboratory, Los Angeles
5. Remuzzi G. Xenotransplantation: a challenge for the future of transplant medicine. Schweizerische Medizinische Wochenschrift. 128:1998;952-960
6. Evans R.W. Coming to terms with reality: why xenotransplantation is a necessity. Platt J.L. Xenotransplantation. 2001;29 ASM Press, Washington, DC
7. Gridelli B., Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med. 343:2000;404-410
8. Mueller Y.M., Davenport C., Ildstad S.T. Xenotransplantation: application of disease resistance. Clin Exp Pharmacol Physiol. 26:1999;1009-1012
9. Starzl T.E., Fung J., Tzakis A., Todo S., Demetris A.J., Marino I.R., et al. Baboon-to-human liver transplantation. Lancet. 341:1993;65-71
10. Platt J.L. Prospects for xenotransplantation. Pediatr Transplant. 3:1999;193-200
11. Platt J.L. Genetic engineering for xenotransplantation. Transplant Proc. 31:1999;1488-1490
12. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Dembitsky S.L.W.W., Long J.W., et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345:2001;1435-1443
13. Nakatani Y., Tanioka T., Sunaga S., Murakami M., Kudo I. Identification of a cellular protein that functionally interacts with the C2 domain of cytosolic phospholipase A(2)alpha. J Biol Chem. 275:2000;1161-1168
14. Hammer C. Xenotransplantation: the good, the bad, and the ugly or how far are we to clinical application? Transplant Proc. 35:2003;1256-1257
15. Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Foundation Symposium. 231:2000;7-15
16. Takeuchi Y., Weiss R.A. Xenotransplantation: reappraising the risk of retroviral zoonosis. Curr Opin Immunol. 12:2000;504-507
17. Boneva R., Folks T.M., Chapman L.E. Infectious disease issues in xenotransplantation. Clin Microbiol Rev. 14:2001;1-14
18. Asano M., Gundry S.R., Izutani H., Cannarella S.N., Fagoaga O., Bailey L.L. Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen. J Thorac Cardiovasc Surg. 125:2003;60-69
19. Patience C., Takeuchi Y., Weiss R.A. Zoonosis in xenotransplantation. Curr Opin Immunol. 10:1998;539-542
20. Van der Laan L.J.W., Lockey C., Griffeth B.C., Frasier F.S., Wilson C.A., Onions D.E., et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature. 407:2000;501-504
21. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W.M., et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science. 285:1999;1236-1241
22. Oldmixon B.A., Wood J.C., Ericsson T.A., Wilson C.A., White-Scharf M.E., Andersson G., et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol. 76:2002;3045-3048
23. Clark D.A., Fryer J.F., Tucker A.W., McArdle P.D., Hughes A.E., Emery V.C., et al. Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control. Xenotransplantation. 10:2003;142-148
24. Ogle B.M., Butters K.B., Plummer T.B., Ring K.R., Knudsen B., Litzow M.R., et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral in vivo. FASEB J. 18:2004;548-550
25. Cascalho M., Platt J.L. The immunological barrier to xenotransplantation. Immunity. 14:2001;437-446
26. Platt J.L., Vercellotti G.M., Dalmasso A.P., Matas A.J., Bolman R.M., Najarian J.S., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today. 11:1990;450-456
27. Platt J.L. Hyperacute xenograft rejection. 1995;RG Landes, Austin, TX
28. Galili U., Clark M.R., Shohet S.B., Buehler J., Macher B.A. Evolutionary relationship between the natural anti-Gal antibody and the Gal α1-3Gal epitope in primates. Proc Natl Acad Sci USA. 84:1987;1369-1373
29. McCurry K.R., Kooyman D.L., Alvarado C.G., Cotterell A.H., Martin M.J., Logan J.S., et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med. 1:1995;423
30. McCurry K.R., Kooyman D.L., Diamond L., Byrne G., Logan J., Platt J.L. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. Transplantation. 59:1995;1177-1182
31. Langford G.A., Yannoutsos N., Cozzi E., Lancaster R., Elsome K., Chen P., et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc. 26:1994;1400-1401
32. Platt J.L., Dalmasso A.P., Vercellotti G.M., Lindman B.J., Turman M.A., Bach F.H. Endothelial cell proteoglycans in xenotransplantation. Transplant Proc. 22:1990;1066
33. White D., Wallwork J. Xenografting: probability, possibility, or pipe dream? Lancet. 342:1993;879-880
34. Lai L., Kolber-Simonds D., Park K.W., Cheong H.T., Greenstein J.L., Im G.S., et al. Production of α-,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science. 295:2002;1089-1092
35. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science. 299:2003;411-414
36. Chopek M.W., Simmons R.L., Platt J.L. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc. 19:1987;4553-4557
37. Bannett A.D., McAlack R.F., Morris M., Chopek M., Platt J.L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc. 21:1989;783-785
38. Platt J.L. New directions for organ transplantation. Nature. 392(Suppl 6679):1998;11-17
39. Bach F.H., Winkler H., Ferran C., Hancock W.W., Robson S.C. Delayed xenograft rejection. Immunol Today. 17:1996;379-384
40. Lin S.S., Hanaway M.J., Gonzalez-Stawinski G.V., Lau C.L., Parker W., Davis R.D., et al. The role of anti-Galα1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation. 70:2000;1667-1674
41. Lin Y., Vandeputte M., Waer M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol. 160:1998;369-375
42. Sato K., Balla J., Otterbein L., Smith R.N., Brouard S., Lin Y., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol. 166:2001;4185-4194
43. Park W.J.P., Grande N.D., Nath K.A., Platt J.L., Gloor J.M., Stegall M.D. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant. 3:2003;952-960
44. Holzknecht Z.E., Platt J.L. Accommodation and the reversibility of biological systems. Transplantation. 71:2001;594-595
45. Schmoeckel M., Bhatti F.N.K., Zaidi A., Cozzi E., Waterworth P.D., Tolan M.J., et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation. 65:1998;1570-1577
46. Sablinski T., Latinne D., Gianello P., Bailin M., Bergen K., Colvin R.B., et al. Xenotransplantation of pig kidneys to nonhuman primates: I. development of the model. Xenotransplantation. 2:1995;264-270
47. Daggett C.W., Yeatman M., Lodge A.J., Chen E.P., Gullotto C., Frank M.M., et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg. 115:1998;19-27
48. Vial C.M., Ostlie D.J., Bhatti F.N., Cozzi E., Goddard M., Chavez G.P., et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant. 19:2000;224-229
49. Xu H., Gundry S.R., Hancock W.W., Matsumiya G., Zuppan C.W., Morimoto T., et al. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg. 115:1998;1342-1349
50. Akhter S.A., Skaer C.A., Kypson A.P., McDonald P.H., Peppel K.C., Glower D.D., et al. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA. 94:1997;12100-12105
51. Buhler L., Basker M., Alwayn I.P.J., Goepfert C., Kitamura H., Kawai T., et al. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation. 70:2000;1323-1331
52. Nishitai R., Plummer T.B., Platt J.L. Detection of albumin synthesis in transplanted porcine hepatocytes in mice. Liver Transplantation. 8:2002;972-974
53. van de Kerkhove M.P., Di Florio E., Scuderi V., Mancini A., Belli A., Bracco A., et al. Phase I clinical trial with the AMC-bioartificial liver. Int J Artif Organs. 25:2002;950-959
54. Smolenski R.T., Raisky O., Kalsi K.K., Abunasra H., Jayakumar J., Suzuki K., et al. Enhanced endogenous adenosine production and protection of the heart after transplantation. Adv Exp Med Biol. 486:2000;167-170
55. Cozzi E., Bhatti F., Schmoeckel M., Chavez G., Smith K.G., Zaidi A., et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation. 70:2000;15-21
56. Wen D., Boissel J., Tracy T.E., Gruninger R.H., Mulcahy L.S., Czelusniak J., et al. Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood. 82:1993;1507-1516
57. Grobstein C. Inductive epithelio-mesenchymal interaction in cultured organ rudiments of the mouse. Science. 118:1953;52-55
58. Ekblom P. Formation of basement membranes in the embryonic kidney: an immunohistological study. J Cell Biol. 91:1981;1-10
59. Rogers S.A., Lowell J.A., Hammerman N.A., Hammerman M.R. Transplantation of developing metanephroi into adult rats. Kidney Int. 54:1998;27-37
60. Rogers S.A., Hammerman M.R. Transplantation of rat metanephroi into mice. Am J Physiol. 280:2001;R1865-R1869
61. Cascalho M., Platt J.L. Xenotransplantation and other means of organ replacement. Nat Rev Immunol. 1:2001;154-160
62. Tannsjo T. Ethical aspects of transplantation surgery. Transplant Proc. 35:2003;1210-1213
63. Cooper D.K., Keogh A.M., Brink J., Corris P.A., Klepetko W., Pierson R.N., et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant. 19:2000;1125-1165
64. Platt J., DiSesa V., Gail D., Massicot-Fisher J. Recommendations of the National Heart, Lung, and Blood Institute Heart and Lung Xenotransplantation Working Group. Circulation. 106:2002;1043-1047
65. Johnston T.D., Katz S.M. Special considerations in the transplant patient requiring other surgery. Surg Clin North Am. 74:1994;1211-1221
66. Black A.E. Anesthesia for pediatric patients who have had a transplant. Int Anesthesiol Clin. 33:1995;107-123
67. Kostopanagiotou G., Smyrniotis V., Arkadopoulos N., Contis J., Briassoulis G., Kostopanagiotou E. Anaesthetic and perioperative management of paediatric organ recipients in nontransplant surgery. Paediatr Anaesth. 13:2003;754-763
68. Kostopanagiotou G., Smyrniotis V., Arkadopoulos N., Theodoraki K., Papadimitriou L., Papadimitriou J. Anesthetic and perioperative management of adult transplant recipients in nontransplant surgery. Anesth Analg. 89:1999;613-622
69. Buhler L., Goepfert C., Kitamura H., Basker M., Gojo S., Alwayn I.P., et al. Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy. Bone Marrow Transplant. 27:2001;1227-1236
70. Alwayn I.P., Buhler L., Basker M., Goepfert C., Kawai T., Kozlowski T., et al. Coagulation/thrombotic disorders associated with organ and cell xenotransplantation. Transplant Proc. 32:2000;1099
71. Buhler L., Alwayn I.P., Appel J.Z. 3rd, Robson S.C., Cooper D.K. Anti-CD154 monoclonal antibody and thromboembolism. Transplantation. 71:2001;491